1. Home
  2. GROV vs XGN Comparison

GROV vs XGN Comparison

Compare GROV & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.30

Market Cap

58.4M

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$3.07

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROV
XGN
Founded
2016
2002
Country
United States
United States
Employees
415
N/A
Industry
Package Goods/Cosmetics
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.4M
64.5M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
GROV
XGN
Price
$1.30
$3.07
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$1.60
$9.14
AVG Volume (30 Days)
91.5K
278.3K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.06
Revenue Next Year
$6.81
$12.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$2.59
52 Week High
$1.60
$12.23

Technical Indicators

Market Signals
Indicator
GROV
XGN
Relative Strength Index (RSI) 44.71 46.86
Support Level $1.19 N/A
Resistance Level $1.35 $3.79
Average True Range (ATR) 0.07 0.21
MACD -0.00 0.05
Stochastic Oscillator 29.17 67.14

Price Performance

Historical Comparison
GROV
XGN

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: